Stephen C. Glover - Net Worth and Insider Trading

Stephen C. Glover Net Worth

The estimated net worth of Stephen C. Glover is at least $199,025 dollars as of 2024-05-24. Stephen C. Glover is the Director of PDS Biotechnology Corp and owns about 63,790 shares of PDS Biotechnology Corp (PDSB) stock worth over $199,025. Details can be seen in Stephen C. Glover's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Stephen C. Glover has not made any transactions after 2021-06-15 and currently still holds the listed stock(s).

Transaction Summary of Stephen C. Glover

To

Stephen C. Glover Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Stephen C. Glover owns 4 companies in total, including PDS Biotechnology Corp (PDSB) , Insmed Inc (INSM) , and ZyVersa Therapeutics Inc (ZVSA) among others .

Click here to see the complete history of Stephen C. Glover’s form 4 insider trades.

Insider Ownership Summary of Stephen C. Glover

Ticker Comapny Transaction Date Type of Owner
PDSB PDS Biotechnology Corp 2021-06-15 director
INSM Insmed Inc 2007-06-22 President Follow-On Biologics
ZVSA ZyVersa Therapeutics Inc 2022-12-12 director & Chief Executive Officer
2023-05-18 director

Stephen C. Glover Latest Holdings Summary

Stephen C. Glover currently owns a total of 1 stock. Stephen C. Glover owns 63,790 shares of PDS Biotechnology Corp (PDSB) as of June 15, 2021, with a value of $199,025.

Latest Holdings of Stephen C. Glover

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
PDSB PDS Biotechnology Corp 2021-06-15 63,790 3.12 199,025

Holding Weightings of Stephen C. Glover


Stephen C. Glover Form 4 Trading Tracker

According to the SEC Form 4 filings, Stephen C. Glover has made a total of 1 transactions in PDS Biotechnology Corp (PDSB) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in PDS Biotechnology Corp is the acquisition of 5,882 shares on June 15, 2021, which cost Stephen C. Glover around $49,997.

Insider Trading History of Stephen C. Glover

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Stephen C. Glover Trading Performance

GuruFocus tracks the stock performance after each of Stephen C. Glover's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Stephen C. Glover is 66.3%. GuruFocus also compares Stephen C. Glover's trading performance to market benchmark return within the same time period. The performance of stocks bought by Stephen C. Glover within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Stephen C. Glover's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Stephen C. Glover

Average Return

Average return per transaction

Outperforming Transactions

0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 6.2
Relative Return to S&P 500(%) 3.53

Stephen C. Glover Ownership Network

Ownership Network List of Stephen C. Glover

No Data

Ownership Network Relation of Stephen C. Glover


Stephen C. Glover Owned Company Details

What does PDS Biotechnology Corp do?

Who are the key executives at PDS Biotechnology Corp?

Stephen C. Glover is the director of PDS Biotechnology Corp. Other key executives at PDS Biotechnology Corp include Senior VP & General Counsel Spencer D. Brown , Chief Financial Officer Matthew C Hill , and director & 10 percent owner Delyle W Bloomquist .

PDS Biotechnology Corp (PDSB) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of PDS Biotechnology Corp (PDSB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of PDS Biotechnology Corp (PDSB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

PDS Biotechnology Corp (PDSB)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

PDS Biotechnology Corp Insider Transactions

No Available Data

Stephen C. Glover Mailing Address

Above is the net worth, insider trading, and ownership report for Stephen C. Glover. You might contact Stephen C. Glover via mailing address: 108 Dockside Circle, Weston Fl 33327.

Discussions on Stephen C. Glover

No discussions yet.